Literature DB >> 25683785

Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS.

A L Gregson1, X Wang, P Injean, S S Weigt, M Shino, D Sayah, A DerHovanessian, J P Lynch, D J Ross, R Saggar, A Ardehali, G Li, R Elashoff, J A Belperio.   

Abstract

Staphylococcus aureus is the most commonly isolated gram-positive bacterium after lung transplantation (LT) and has been associated with poor posttransplant outcomes, but its effect on bronchiolitis obliterans syndrome (BOS) and death in the context of the allograft inflammatory environment has not been studied. A three-state Cox semi-Markovian model was used to determine the influence of allograft S. aureus and the ELR+ CXC chemokines on the survival rates and cause-specific hazards for movement from lung transplant (State 1) to BOS (State 2), from transplant (State 1) to death (State 3), and from BOS (State 2) to death (State 3). Acute rejection, pseudomonas pneumonia, bronchoalveolar lavage fluid (BALF) CXCL5 and its interaction with S. aureus all increased the likelihood of transition from transplant to BOS. Transition to death from transplant was facilitated by pseudomonas infection and single lung transplant. Movement from BOS to death was affected by the interaction between aspergillus, pseudomonas and CXCL5, but not S. aureus. S. aureus isolation had state specific effects after LT and only in concert with elevated BALF CXCL5 concentrations did it augment the risk of BOS. Pseudomonas and elevated BALF concentrations of CXCL5 continued as significant risk factors for BOS and death after BOS in lung transplantation. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Bacterial; bronchiolitis obliterans (BOS); chemokines/chemokine receptors; clinical research; immune regulation; infection and infectious agents; infectious disease; lung transplantation; practice; pulmonology; rejection: chronic; science; translational research

Mesh:

Substances:

Year:  2015        PMID: 25683785      PMCID: PMC4336208          DOI: 10.1111/ajt.13029

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  26 in total

Review 1.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

2.  Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.

Authors:  Maricar F Malinis; Steven D Mawhorter; Anil Jain; Nabin K Shrestha; Robin K Avery; David van Duin
Journal:  Transplantation       Date:  2012-05-27       Impact factor: 4.939

3.  Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Brigitte Gomperts; Ying Ying Xue; Kurt Hong; Javier Mestas; Abbas Ardehali; Borna Mehrad; Rajan Saggar; Joseph P Lynch; David J Ross; Robert M Strieter
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.

Authors:  S S Weigt; A Derhovanessian; E Liao; S Hu; A L Gregson; B M Kubak; R Saggar; R Saggar; V Plachevskiy; M C Fishbein; J P Lynch; A Ardehali; D J Ross; H-J Wang; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2011-12-07       Impact factor: 8.086

5.  Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.

Authors:  Aric L Gregson; Xiaoyan Wang; S Sam Weigt; Vyacheslav Palchevskiy; Joseph P Lynch; David J Ross; Bernard M Kubak; Rajan Saggar; Michael C Fishbein; Abbas Ardehali; Gang Li; Robert Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

6.  Transient airway colonization is associated with airway inflammation after lung transplantation.

Authors:  R Vos; B M Vanaudenaerde; L J Dupont; D E Van Raemdonck; G M Verleden
Journal:  Am J Transplant       Date:  2007-05       Impact factor: 8.086

7.  Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

Authors:  Susan Stewart; Michael C Fishbein; Gregory I Snell; Gerald J Berry; Annette Boehler; Margaret M Burke; Alan Glanville; F Kate Gould; Cynthia Magro; Charles C Marboe; Keith D McNeil; Elaine F Reed; Nancy L Reinsmoen; John P Scott; Sean M Studer; Henry D Tazelaar; John L Wallwork; Glen Westall; Martin R Zamora; Adriana Zeevi; Samuel A Yousem
Journal:  J Heart Lung Transplant       Date:  2007-12       Impact factor: 10.247

8.  Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.

Authors:  Phil Botha; Lynda Archer; Rachel L Anderson; Jim Lordan; John H Dark; Paul A Corris; Kate Gould; Andrew J Fisher
Journal:  Transplantation       Date:  2008-03-15       Impact factor: 4.939

9.  Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes.

Authors:  Ryan K Shields; Cornelius J Clancy; Lucio R Minces; Eun J Kwak; Fernanda P Silveira; Rima C Abdel Massih; Yoshiya Toyoda; Christian Bermudez; Jay K Bhama; Norihisa Shigemura; Joseph M Pilewski; Maria Crespo; M Hong Nguyen
Journal:  J Heart Lung Transplant       Date:  2012-09-15       Impact factor: 10.247

10.  Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study.

Authors:  M Aguilar-Guisado; J Givaldá; P Ussetti; A Ramos; P Morales; M Blanes; G Bou; J de la Torre-Cisneros; A Román; J M Borro; R Lama; J M Cisneros
Journal:  Am J Transplant       Date:  2007-08       Impact factor: 8.086

View more
  12 in total

1.  Altered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute Rejection.

Authors:  Aric L Gregson; Aki Hoji; Patil Injean; Steven T Poynter; Claudia Briones; Vyacheslav Palchevskiy; S Sam Weigt; Michael Y Shino; Ariss Derhovanessian; David Sayah; Rajan Saggar; David Ross; Abbas Ardehali; Joseph P Lynch; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

2.  Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.

Authors:  John Belperio; Scott M Palmer; S Sam Weigt
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 3.  The role of the immune system in lung transplantation: towards improved long-term results.

Authors:  Ramsey R Hachem
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Gene Expression Profiling of Bronchoalveolar Lavage Cells During Aspergillus Colonization of the Lung Allograft.

Authors:  S Samuel Weigt; Xiaoyan Wang; Vyacheslav Palchevskiy; Naman Patel; Ariss Derhovanessian; Michael Y Shino; David M Sayah; Joseph P Lynch; Rajan Saggar; David J Ross; Bernie M Kubak; Abbas Ardehali; Scott Palmer; Shahid Husain; John A Belperio
Journal:  Transplantation       Date:  2018-06       Impact factor: 4.939

5.  Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.

Authors:  Michael Y Shino; Jamie L Todd; Megan L Neely; Jerry Kirchner; Courtney W Frankel; Laurie D Snyder; Elizabeth N Pavlisko; Gregory A Fishbein; Joanna M Schaenman; Kristen Mason; Karen Kesler; Tereza Martinu; Lianne G Singer; Wayne Tsuang; Marie Budev; Pali D Shah; John M Reynolds; Nikki Williams; Mark A Robien; Scott M Palmer; S Sam Weigt; John A Belperio
Journal:  Am J Transplant       Date:  2022-06-15       Impact factor: 9.369

Review 6.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

7.  Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.

Authors:  Paul R Allyn; Erin L Duffy; Romney M Humphries; Patil Injean; S Samuel Weigt; Rajan Saggar; Michael Y Shino; Joseph P Lynch; Abbas Ardehali; Bernard Kubak; Chi-Hong Tseng; John A Belperio; David J Ross; Aric L Gregson
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

8.  Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.

Authors:  Katrina Bazemore; Michael Rohly; Nitipong Permpalung; Kai Yu; Irina Timofte; A Whitney Brown; Jonathan Orens; Aldo Iacono; Steven D Nathan; Robin K Avery; Hannah Valantine; Sean Agbor-Enoh; Pali D Shah
Journal:  J Heart Lung Transplant       Date:  2021-05-30       Impact factor: 10.247

9.  Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.

Authors:  Michael Y Shino; Ning Li; Jamie L Todd; Megan L Neely; Jerry Kirchner; Heather Kopetskie; Michelle L Sever; Courtney W Frankel; Laurie D Snyder; Elizabeth N Pavlisko; Tereza Martinu; Lianne G Singer; Wayne Tsuang; Marie Budev; Pali D Shah; John M Reynolds; Nikki Williams; Mark A Robien; Scott M Palmer; Stephen Sam Weigt; John A Belperio
Journal:  Am J Transplant       Date:  2021-06-16       Impact factor: 9.369

10.  Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.

Authors:  Hrishikesh S Kulkarni; Kevin Tsui; Suraj Sunder; Alex Ganninger; Laneshia K Tague; Chad A Witt; Derek E Byers; Elbert P Trulock; Ruben Nava; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Andrew E Gelman; Ramsey R Hachem
Journal:  Am J Transplant       Date:  2019-12-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.